好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Impact of a Non-mydriatic Ocular Fundus Camera at a Quaternary Care Emergency Department
Neurohospitalist
P4 - Poster Session 4 (11:45 AM-12:45 PM)
15-001

To evaluate the short-term impact of the implementation of a non-mydriatic ocular fundus camera in a busy emergency department (ED) in a metropolitan quaternary care hospital.

Ocular funduscopic examinations are rarely performed by non-ophthalmology providers, resulting in diagnostic errors and worse patient outcomes, and are of particular concern in EDs where ophthalmologists are not always available.

Quality improvement project with systematic prospective collection of data from patients who had ocular fundus photographs taken in the ED for visual complaints, headaches, neurologic symptoms, “papilledema”, hypertensive crisis. We collected demographic information, indication for fundus photographs, who ordered photographs, timing of photographs, final diagnosis, and whether photographs had an impact on patients’ length of ED stay and final outcomes.

Over 4 months, 385 patients had photographs (ordered by ED 89.3%, ophthalmology 7.7%, neurology 3.0%). Reasons included visual complaint 34.8%, headache 14.3%, papilledema 14.6%, other neurologic complaints 35.3%, hypertension 0.8%, diabetes 0.3%. Photographs were interpreted remotely, avoiding ophthalmology or neurology in-person consultation in 10.9%. Obtaining photographs took <5 minutes (60.2% high quality; 75.2% able to exclude emergent findings). Photographs accelerated the management/disposition of patients with acute disorders in 56.3%, including 13 acute central retinal arterial occlusions, 5 giant cell arteritis, 44 papilledema.

Incorporating a non-mydriatic ocular fundus camera into the ED workflow can be used as a substitute for non-ophthalmology provider funduscopic examinations in most cases, facilitating remote fundus interpretation by ophthalmologists and real-time remote recommendations without seeing patients in person. These positive preliminary results obtained only 4 months after implementation of the camera suggest that this strategy reduces the overall ED stay and accelerates the diagnosis of urgent vision- or life-threatening conditions, resulting in improved patient outcomes. Further data will be collected and results of the first 9 months (estimated >1000 consecutive patients) will be presented at the AAN meeting. 

Authors/Disclosures
Valerie Biousse, MD
PRESENTER
Dr. Biousse has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gensights Biologic. Dr. Biousse has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Topcon. Dr. Biousse has received publishing royalties from a publication relating to health care. Dr. Biousse has received publishing royalties from a publication relating to health care.
Mariana Rodriguez Duran No disclosure on file
Mariam Torres Soto (Emory University School of Medicine) No disclosure on file
Andrew Pendley No disclosure on file
Gabriele Berman, MD (Emory Eye Center, Neuro-Ophthalmology Unit) Dr. Berman has nothing to disclose.
James Greene, MD, PhD (Emory University) Dr. Greene has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink Neurology.
David Wright (Emory) David Wright has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbott. David Wright has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astrocyte Pharmaceutical . David Wright has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for several defense legal firms. David Wright has stock in Astrocyte Pharmaceuticals. The institution of David Wright has received research support from NINDS. The institution of David Wright has received research support from Department of Defense. The institution of David Wright has received research support from Marcus Foundation. The institution of David Wright has received research support from Nico Corporation. The institution of David Wright has received research support from Center for Disease Control. David Wright has received intellectual property interests from a discovery or technology relating to health care.
Nancy J. Newman, MD, FAAN (Emory University School of Medicine) Dr. Newman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for GenSight. Dr. Newman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Chiesi. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Newman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Phelcom. The institution of Dr. Newman has received research support from GenSight. Dr. Newman has received publishing royalties from a publication relating to health care. Dr. Newman has received publishing royalties from a publication relating to health care. Dr. Newman has received publishing royalties from a publication relating to health care.